FierceBiotech

Incyte’s decision to scrap work…

news2025-10-28T08:34:00+00:00October 28th, 2025|FierceBiotech|

GSK’s antibody-drug conjugate…

news2025-10-28T05:43:00+00:00October 28th, 2025|FierceBiotech|

With a new approach to creating…

news2025-10-27T19:33:00+00:00October 27th, 2025|FierceBiotech|

Late-stage ovarian cancer trials…

news2025-10-27T15:18:00+00:00October 27th, 2025|FierceBiotech|

The number of biopharma M&A…

news2025-10-27T12:27:00+00:00October 27th, 2025|FierceBiotech|

Intellia Therapeutics has…

news2025-10-27T09:20:00+00:00October 27th, 2025|FierceBiotech|

Zenas Biopharma’s lead…

news2025-10-27T08:32:00+00:00October 27th, 2025|FierceBiotech|

MapLight Therapeutics is heading…

news2025-10-27T05:34:00+00:00October 27th, 2025|FierceBiotech|

BridgeBio has vaulted over the…

news2025-10-27T04:09:00+00:00October 27th, 2025|FierceBiotech|

Fresh from a European cancer…

news2025-10-27T04:08:00+00:00October 27th, 2025|FierceBiotech|

Previous192021Next